Fundz
Back to SEC Filings
10-QMEDIUM RiskSTABLE

MEDIFAST INC

Filed: May 4, 2026 CIK: 0000910329
View original filing on SEC.gov

AI Executive Summary

AI-powered analysis of 10-Q filing content

Medifast is executing a strategic transformation from weight loss to broader metabolic health services, maintaining approximately 14,000 active coaches and a well-capitalized position. The company entered into a cooperation agreement with Steamboat Capital Partners in March 2026, suggesting potential activist investor involvement.

Red Flags Detected (4)

Stock price declined from $10.82 to $9.63 between February and March 2026 (11% drop)

Company is subject to various litigation proceedings in ordinary course of business

No actual share repurchases under authorized plan despite 1.3M shares available since 2014

1 more red flag detected

Key Takeaways

Strategic pivot from weight loss to metabolic health market targeting broader customer base

Maintains strong coach network of ~14,000 active earning coaches with 90% being former clients

2 more takeaways

Filing Overview

Form TypeQuarterly Report (10-Q)
Filing DateMay 4, 2026
Risk LevelMEDIUM
TrendSTABLE
AI Confidence75%
Red Flags4

What This Means

Quarterly Report: Interim filing with unaudited financial data for the quarter.

View Full Filing on SEC.govBrowse More Filings